Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity.
D000818:Animals; D000917:Antibody Formation; D001152:Arsenicals; D001391:Azo Compounds; D002351:Carrageenan / Q000494:pharmacology; D000939:Epitopes; D005260:Female; D006168:Guinea Pigs; D006241:Haptens; D006968:Hypersensitivity, Delayed / Q000209:etiology*; D007110:Immunity, Active; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D013329:Structure-Activity Relationship; D014443:Tyrosine
D001152:Arsenicals; D001391:Azo Compounds; D000939:Epitopes; D006241:Haptens; D014443:Tyrosine; D002351:Carrageenan